Peripheral Arterial Disease Trial, Recruiting NCT06332911 Sponsor: Rede Optimus Hospitalar SA Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06332911
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older at the time of enrolling in the trial.
  • People who have been diagnosed with a large bulge (aneurysm) in the major blood vessel of the chest and/or abdomen that requires a specific type of internal repair using a custom-fitted device delivered through a tube 18 French (about 6mm) or larger in diameter.
  • People whose hip/groin arteries (iliac arteries) are difficult to access due to heavy calcium buildup around the full circumference of the artery, a very narrow inner width (6mm or less), or significant blockage reducing blood flow.
  • People whose aneurysm repair is needed urgently, is planned in advance (elective), is causing symptoms, or where the aneurysm is growing quickly.
  • People whose procedure involved the use of a Shockwave™ device to treat the calcified arteries before the main repair device was inserted, with or without additional balloon widening or stent placement.

Who may not be able to join:

  • People who had a surgical bypass procedure (a detour route surgically created to go around a blocked artery) to allow access for the repair.
  • People whose arteries do not have severe calcium buildup, or have no calcium buildup at all.
  • People who have a blockage or narrowing inside a previously placed stent in the relevant artery.
  • People whose arteries could not be crossed with a very fine guidewire (a thin wire used to guide medical devices) during the procedure.
  • People with a significant medical condition that, in the opinion of the medical team running the trial, could affect safe participation.
  • People who already had a stent placed in the hip/groin arteries at the site where the Shockwave™ device would be used.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc Bosiers, Dr., Rede Optimus Hospitalar AG

Phone: +49 157 80 58 5869

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rede Optimus Hospitalar SA
Registry
ClinicalTrials.gov
Start date
19 May 2025
Est. completion
30 May 2026

Where this trial is recruiting

🇩🇪 Germany 🇮🇹 Italy 🇨🇭 Switzerland

Primary endpoints

Efficacy: Technical success - defined as intention-to-treat basis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov